Everyone with diabetes is at risk of losing vision. Good control of blood glucose, blood pressure and blood lipids as well as timely treatment can reduce the incidence of eye disease and vision loss.
As part of the Diabetic Retinopathy Barometer project we are asking healthcare professionals and people with diabetes to participate in a global survey to help us better understand awareness levels around retinopathy and services available.
By early 2014, it had become clear that rapid advances in anti-vascular endothelial growth factor (VEGF) therapies were revolutionizing the treatment of DME — and the field of ophthalmology. Recognizing the clinically transformative nature of these remarkable therapies, the Angiogenesis Foundation decided that it was an opportune time to bring